Who gets Alzheimer?

['Dangarakan halaman ngini']

Siapa nang kena Alzheimer?

Penyakit Alzheimer adalah gangguan neurodegeneratif progresif nang terutama mempengaruhi urang dewasa nang lebih tuha.

Risiko mangambangakan panyakit Alzheimer maningkat lawan umur, wan paling umum pada urang nang baumur labih matan 65 tahun.

Namun, Alzheimer nang pamulaan kawa tajadi pada urang-urang dalam usia 30-an, 40-an, wan 50-an, walaupun ini jarang tajadi.

Genetika jua baparan dalam parkambangan penyakit Alzheimer.

Urang nang baisi riwayat kaluarga panyakit ngini baisi risiko labih tinggi gasan maningkatakan panyakitnya saurang.

Selain itu, mutasi genetik tertentu, nang kaya gen APOE-e4, kawa meningkatkan kemungkinan mengembangkan Alzheimer.

Faktor risiko lain gasan penyakit Alzheimer termasuk riwayat luka di kapala, penyakit kardiovaskular, wan faktor gaya hidup nang kaya merokok, obesitas, wan kurang olahraga.

Penting dicatat amun beberapa faktor kawa maningkatakan risiko mengidap penyakit Alzheimer, itu lain bagian normal dari penuaan, wan kada setiap urang nang umurnya meningkat akan mengidap penyakit ini.

['Rujukan nang lain']

PubMed/Medline https://www.nlm.nih.gov/databases/download/pubmed_medline.html

RefinedWeb https://arxiv.org/abs/2306.01116

Kovacs GG: Can Creutzfeldt-Jakob disease unravel the mysteries of Alzheimer? Prion. 2016, 10 (5): 369-376.

Cankurtaran M, Yavuz BB, Cankurtaran ES, Halil M, Ulger Z, Ariogul S: Risk factors and type of dementia: vascular or Alzheimer? Arch Gerontol Geriatr. , 47 (1): 25-34.

Mahami-Oskouei M, Hamidi F, Talebi M, Farhoudi M, Taheraghdam AA, Kazemi T, Sadeghi-Bazargani H, Fallah E: Toxoplasmosis and Alzheimer: can Toxoplasma gondii really be introduced as a risk factor in etiology of Alzheimer? Parasitol Res. 2016, 115 (8): 3169-74.

Vellas B, Andrieu S, Cantet C, Dartigues JF, Gauthier S: Long-term changes in ADAS-cog: what is clinically relevant for disease modifying trials in Alzheimer? J Nutr Health Aging. , 11 (4): 338-41.

Bakhtiari S, Moghadam NB, Ehsani M, Mortazavi H, Sabour S, Bakhshi M: Can Salivary Acetylcholinesterase be a Diagnostic Biomarker for Alzheimer? J Clin Diagn Res. 2017, 11 (1): ZC58-ZC60.

['Penafian: medis']

['Situs web ngini disediakan gasan tujuan pendidikan wan informasi haja wan kada merupakan penyediaan nasihat medis atawa layanan profesional.']

['Informasi nang disadiaakan kada boleh dipakai gasan mendiagnosis atawa mengobati masalah kesehatan atawa penyakit, wan buhannya nang mencari nasihat medis pribadi harus berkonsultasi lawan dokter berlisensi.']

['Harap dicatat jaringan saraf nang menghasilkan jawaban gasan pertanyaan, adalah khusus kada akurat pas menyangkut isi numerik. misalnya, jumlah urang nang didiagnosis lawan penyakit tertentu.']

['Salalu minta nasehat dokter atau panyadia kasihatan lain nang kualifikasi manganai kondisi medis. Jangan pernah mengabaikan nasehat medis profesional atawa manunda dalam mancarinya karana sesuatu nang sudah Pian baca di situs web ngini. Amun Pian pikir Pian mungkin baisi darurat medis, hubungi 911 atawa langsung ka ruang gawat darurat parak. Kadada hubungan dokter-pasien nang diulah ulih situs web ngini atawa pamakaiannya. BioMedLib maupun karyawannya, atawa kontributor situs web ngini, kada maulah pernyataan, langsung atawa kada langsung, manganai informasi nang disadiaakan di sini atawa pamakaiannya.']

['Penafian: hak cipta']

['Digital Millennium Copyright Act tahun 1998, 17 U.S.C. § 512 (DMCA) menyediakan jalan bagi pemilik hak cipta nang percaya bahwa materi nang muncul di Internet melanggar hak buhannya di bawah hukum hak cipta AS. ']

['Amun Pian yakin amun konten atawa materi apa haja nang tasadia dalam hubungannya lawan situs web atawa layanan kami malanggar hak cipta Pian, Pian (atawa agen Pian) kawa mangirim kami pasan maminta supaya konten atawa materi dihapus, atawa aksesnya diblokir.']

['Pemberitahuan harus dikirim secara tertulis lewat email (lihat bagian "Kontak" gasan alamat email). ']

['DMCA mamarluakan bahwa pemberitahuan dugaan pelanggaran hak cipta tamasuk informasi barikut: (1) deskripsi karya berhak cipta nang merupakan subjek klaim pelanggaran; (2) deskripsi konten dugaan pelanggaran wan informasi nang cukup gasan mamungkinakan kami manamui konten; (3) informasi kontak gasan Pian, tamasuk alamat, nomor telepon wan alamat email Pian; (4) pernyataan Pian bahwa Pian baiman baik bahwa konten dalam cara nang diklaim kada diizinkan oleh pemilik hak cipta, atau agennya, atau oleh operasi hukum apa pun; ']

['(5) pernyataan Pian, nang ditandatangani lawan hukuman sumpah palsu, bahwa informasi dalam pemberitahuan akurat wan Pian baisi wewenang gasan manegakkan hak cipta nang diklaim dilanggar; ']

['wan (6) tanda tangan fisik atawa elektronik ampun ampun hak cipta atawa urang nang baisi wewenang gasan bagawi atas ampun ampun hak cipta. ']

['Gagal mancakup samua inpurmasi di atas kawa manyababakan panundaan pangolahan sambatan Pian.']

['Kontak lawan']

['Silakan kirim email lawan kami amun ada pertanyaan/usulan.']

Who gets alzheimer?

Alzheimer's disease is a progressive neurodegenerative disorder that primarily affects older adults.

The risk of developing Alzheimer's disease increases with age, and it is most common in people over the age of 65.

However, early-onset Alzheimer's can occur in people in their 30s, 40s, and 50s, although this is less common.

Genetics also play a role in the development of Alzheimer's disease.

People with a family history of the disease are at a higher risk of developing it themselves.

Additionally, certain genetic mutations, such as the APOE-e4 gene, can increase the likelihood of developing Alzheimer's.

Other risk factors for Alzheimer's disease include a history of head injuries, cardiovascular disease, and lifestyle factors such as smoking, obesity, and lack of exercise.

It is important to note that while certain factors can increase the risk of developing Alzheimer's disease, it is not a normal part of aging, and not everyone who ages will develop the disease.

Disclaimer: medical

This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.

The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.

Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.

Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.

Disclaimer: copyright

The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.